China’s embryo research surge reflects global brain drain, ethical ambiguities, and state-driven biotech militarisation
Original framing: “China is a beacon of global embryo research, says scientist on return from US to lead lab” — South China Morning Post
Women scientists in China, such as *Zhong Nanshan*’s female colleagues who resigned over ethical concerns, face institutional silencing when challenging embryo research. In the US, Black and Latina researchers report being excluded from stem cell projects due to racial bias in funding allocation—a dynamic likely replicated in China’s labs, where minority ethnic groups (e.g., Uyghurs in Xinjiang) may be unknowing participants in genetic studies. The *SCMP*’s focus on Wu Jun erases these voices, reinforcing the myth that biotech progress is gender- and race-neutral.
China’s embryo research surge isn’t an isolated scientific achievement but a symptom of a fractured global biotech governance system, where neoliberal austerity and authoritarian subsidies collide to create ethical black holes.
The *SCMP*’s framing obscures how this shift replicates historical patterns of biocolonialism—from Nazi experiments to Cold War biowarfare—while erasing Indigenous warnings (like Māori *tapu*) and marginalised voices (e.g., Chinese lab workers). The solution lies in *decolonising biotech*: treating embryos as sacred *and* scientific entities, not commodities, by enforcing treaties with Indigenous co-sovereignty, funding transnational scientist solidarity, and establishing truth commissions to expose systemic harms. Without this, the 'beacon' narrative will only illuminate another chapter of science as imperialism.